![]() Teglicar structure
|
Common Name | Teglicar | ||
---|---|---|---|---|
CAS Number | 250694-07-6 | Molecular Weight | 399.61100 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H45N3O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of TeglicarTeglicar is a selective and reversible inhibitor of liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1). Teglicar reduces ketogenesis and glucose production, decreases gluconeogenesis and improves glucose homeostasis. Teglicar has a potential antihyperglycemic propert[1]. |
Name | Teglicar |
---|---|
Synonym | More Synonyms |
Description | Teglicar is a selective and reversible inhibitor of liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1). Teglicar reduces ketogenesis and glucose production, decreases gluconeogenesis and improves glucose homeostasis. Teglicar has a potential antihyperglycemic propert[1]. |
---|---|
Related Catalog | |
Target |
IC50: L-CPT1[1] |
References |
Molecular Formula | C22H45N3O3 |
---|---|
Molecular Weight | 399.61100 |
Exact Mass | 399.34600 |
PSA | 81.26000 |
LogP | 3.98330 |
(R)-4-Trimethylammonio-3-[(tetradecylcarbamoyl)amino]butyrate |
ST 1326 |
3-(TETRADECYLCARBAMOYLAMINO)-4-TRIMETHYLAMMONIO-BUTANOATE |
1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[[(tetradecylamino)carbonyl]amino]-,inner salt,(2R) |
R-4-trimethylammonium-3-(tetradecylcarbamoyl)-aminobutyrate |
3-(tetradecylcarbamoylamino)-4-(trimethylazaniumyl)butanoate |
4-trimethylammonium-(R)-3-(tetradecylcarbamoyl)-amino butyrate |